openPR Logo
Press release

Key Trend Reshaping the Panuveitis Market in 2025: Advancements In Slow-Release Intravitreal Injection Therapies For Retinal Diseases

03-25-2025 05:58 AM CET | Health & Medicine

Press release from: The Business Research Company

Panuveitis

Panuveitis

What combination of drivers is leading to accelerated growth in the panuveitis market?
The rising prevalence of autoimmune disorders is expected to propel the growth of the panuveitis market. Autoimmune diseases occur when the immune system mistakenly attacks the body's healthy cells and tissues. Factors such as genetic predisposition, environmental factors like pollution and dietary changes, and increased exposure to infections contribute to the rise in autoimmune disorders. These disorders lead to advancements in panuveitis treatment by driving research into immune system modulation, as many cases of panuveitis are linked to autoimmune activity. For example, in May 2023, the University of Oxford reported that autoimmune diseases affect 10% of the global population, with 13% of women and 7% of men affected. Therefore, the rising prevalence of autoimmune disorders is driving the growth of the panuveitis market.

Get Your Panuveitis Market Report Here:
https://www.thebusinessresearchcompany.com/report/panuveitis-global-market-report

What is the projected compound annual growth rate (CAGR) of the panuveitis market from 2025 to 2034, and what factors influence it?
The panuveitis market has expanded rapidly, growing from $4.05 billion in 2024 to $4.47 billion in 2025 at a CAGR of 10.5%. Growth factors include the increasing prevalence of autoimmune and infectious diseases, greater use of corticosteroids, rising adoption of biologics, a higher demand for ophthalmic imaging, and growing research investments in infectious causes.

The panuveitis market is set for rapid expansion, reaching $6.58 billion by 2029, at a CAGR of 10.2%. Growth will be driven by the increasing use of biologic therapies, rising demand for personalized medicine, a higher prevalence of uveitis-related conditions, greater investments in ophthalmic research, and growing disease awareness. Key trends include adoption of biologic therapies, development of sustained-release drug delivery systems, advancements in AI-driven diagnosis and treatment, expansion of personalized medicine, and minimally invasive surgical techniques.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21244&type=smp

How are the latest trends influencing the growth of the panuveitis market?
In the panuveitis market, companies are developing slow-release intravitreal injection formulations to improve patient compliance and therapeutic outcomes. These formulations gradually release medication into the eye, reducing the need for frequent dosing. For instance, Tarsier Pharma, an Israel-based clinical-stage company, is developing TRS02, an immunomodulator for treating retinal diseases like panuveitis and diabetic macular edema. This therapy is progressing toward investigational new drug (IND) submission following successful preclinical milestones.

What are the major segments of the panuveitis market and their role in driving growth?
The panuveitis market covered in this report is segmented -

1) By Type: Infectious Panuveitis, Non-Infectious Panuveitis
2) By Treatment: Pharmacological, Surgical, Phototherapy
3) By Route Of Administration: Oral, Intravitreal, Topical
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Infectious Panuveitis: Bacterial Panuveitis, Viral Panuveitis, Fungal Panuveitis, Parasitic Panuveitis
2) By Non-Infectious Panuveitis: Autoimmune-Related Panuveitis, Idiopathic Panuveitis, Drug-Induced Panuveitis

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21244

Which regions are key players in the growth of the panuveitis market?
North America was the largest region in the panuveitis market in 2024. The regions covered in the panuveitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the panuveitis market?
Major companies operating in the panuveitis market are Pfizer Inc., AbbVie, Boehringer Ingelheim International GmbH, Amgen, Teva Pharmaceuticals, Sandoz, Organon group of companies, Zydus Lifesciences Ltd., Mallinckrodt plc, Alvotech, EyePoint Pharmaceuticals Inc., Affibody Medical AB, Alumis Inc., Fujifilm Kyowa Kirin Biologics Co. Ltd., Revolo Biotherapeutics Ltd., Tarsier Pharma, Priovant Therapeutics Inc., Mylan N.V., Clearside Biomedical Inc., pSivida Corp.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21244&type=smp

What Is Covered In The Panuveitis Global Market Report?

•Market Size Forecast: Examine the panuveitis market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the panuveitis market for a structured understanding.
•Key Players Overview: Analyze major players in the panuveitis market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the panuveitis market.
•Segment Contributions: Evaluate how different segments drive overall growth in the panuveitis market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the panuveitis market.
•Industry Challenges: Identify potential risks and obstacles affecting the panuveitis market.
•Competitive Landscape: Review strategic developments in the panuveitis market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Key Trend Reshaping the Panuveitis Market in 2025: Advancements In Slow-Release Intravitreal Injection Therapies For Retinal Diseases here

News-ID: 3934528 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Panuveitis

Global Panuveitis Treatment Market Expected to Achieve 9.3% CAGR by 2029: Growth …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Panuveitis Treatment Market Size By 2025? The market encompassing treatments for panuveitis has experienced robust expansion lately, projected to escalate from a valuation of $3.98 billion in the year 2024 to $4.35 billion come 2025, demonstrating a consistent compound annual growth rate (CAGR) reaching 9.3%.
Panuveitis Market to Reach USD 2.9 Billion by 2034
Panuveitis is a severe form of uveitis in which all layers of the uvea (iris, ciliary body, and choroid) are inflamed. It often results in blurred vision, eye pain, redness, light sensitivity, and floaters. The condition can be triggered by autoimmune diseases, infections, or idiopathic causes, and if untreated, can cause irreversible vision loss, glaucoma, cataracts, and retinal complications. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72271 The increasing prevalence
Elevated Prevalence Of Eye-Related Diseases Fuels Growth In The Panuveitis Treat …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts What Will the Panuveitis Treatment Industry Market Size Be by 2025? There has been a swift expansion in the panuveitis treatment market in the previous years. It is set to rise from a value of $3.98 billion in 2024 to a noteworthy $4.4 billion in 2025, showcasing a compound
Panuveitis Treatment Market Forecast 2025-2034: Comprehensive Analysis And Growt …
The Panuveitis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Panuveitis Treatment Market? The market for panuveitis treatment has experienced swift expansion in recent years. An increase from $3.98 billion in 2024 to $4.4 billion in 2025, with
Clearside Biomedical Inc. Revolutionizes Panuveitis Treatment With Innovative Xi …
What Is the Expected Size and Growth Rate of the Panuveitis Treatment Market? The panuveitis treatment market has experienced rapid growth in recent years. It will grow from $3.98 billion in 2024 to $4.4 billion in 2025, at a CAGR of 10.5%. This growth is driven by the rising prevalence of uveitis, increased awareness and early diagnosis, improved drug delivery systems, patient advocacy initiatives, and government support and regulatory approvals. The panuveitis
Panuveitis Treatment Market Forecast 2024-2033 - Major Trends, Segments And Fast …
"The Business Research Company recently released a comprehensive report on the Global Panuveitis Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The panuveitis treatment market size